Abstract
Background
Preeclampsia (PE) and chronic kidney disease (CKD) are linked by an only partially known cause-effect relationship. Knowledge on prevalence of CKD in PE patients is needed for evaluating the diagnostic yield of nephrology work-up after PE.
Methods
The study was undertaken in the Centre Hospitalier Le Mans (CHM), setting of tertiary level obstetric service (about 3500 deliveries/year). PE was identified on hospital’s discharge codes; after review, the study included 99 patients, 36 of which were also evaluated in Nephrology. A descriptive analysis was performed as appropriate. Logistic multiple regression tested the outcome “CKD diagnosis”; covariates that emerged as significant were selected; only singletons were included. Analysis was performed in SPSS. The ethics committee of the CHM approved the study.
Results
Prevalence of CKD was 14%; CKD was in stage 1 in 8/14 (57%); 5 patients were in stage 2 (36%), 1 in stage 3 (7%). CKD was known or acknowledged in 1 case only. Diagnoses included reflux nephropathy-other malformations (5 cases), kidney stones-chronic pyelonephritis (3), PKD (1), interstitial nephropathy (2), diabetic nephropathy (1), albuminuria in metabolic syndrome (2). At the logistic regression analysis, preterm delivery [OR 7.849 (1.667–36.968)] and a baby normal for gestational age [> 10th centile; OR 6.193 (1.400–27.394)] were significantly correlated with the diagnosis of CKD.
Conclusions
Within the limits of a single-center study, our data quantify CKD as common in PE women and suggest the presence of a “CKD phenotype” characterised by preterm delivery and adequate growth, implying that CKD is compatible with good placental function up to the last phase of pregnancy.
Similar content being viewed by others
References
Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376:631–644
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ (2016) Pre-eclampsia. Lancet 387:999–1011
Phipps E, Prasanna D, Brima W, Jim B (2016) Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol 11:1102–1113
Hutcheon JA, Lisonkova S, Joseph KS (2011) Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 25:391–403
Premkumar A, Baer RJ, Jelliffe-Pawlowski LL, Norton ME (2019) Hypertensive disorders of pregnancy and preterm birth rates among black women. Am J Perinatol. 36(2):148–154. https://doi.org/10.1055/s-0038-1660461
Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z et al (2013) Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet 381(9879):1747–1755
Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, Souza JP (2014) WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 121(Suppl 1):14–24
Ukah UV, Payne B, Hutcheon JA, Ansermino JM, Ganzevoort W, Thangaratinam S, Magee LA, von Dadelszen P (2018) Assessment of the fullPIERS risk prediction model in women with early-onset preeclampsia. Hypertension 71(4):659–665
Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP (2005) Preeclampsia: a renal perspective. Kidney Int 67(6):2101–2113
August P (2013) Preeclampsia: a “nephrocentric” view. Adv Chronic Kidney Dis 20(3):280–286
Paauw ND, Lely AT (2018) Cardiovascular sequels during and after preeclampsia. Adv Exp Med Biol 1065:455–470
Thadhani R, Solomon CG (2008) Preeclampsia: a glimpse into the future? N Engl J Med 359(8):858–860
Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359(8):800–809
Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE (2013) Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382(9888):273–283
Piccoli GB, Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Spotti D, Giacchino F, Attini R, Limardo M, Maxia S, Fois A, Gammaro L, Todros T (2017) Kidney and Pregnancy Study Group of Italian Society of Nephrology. A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J Nephrol 30(3):307–317
Pourrat O, Pierre F (2010) Medical assessment after a pre-eclampsia: Why? For whom? When? How? For what purpose? Rev Med Interne 31(11):766–771
Kamravamanesh M, Kohan S, Rezavand N, Farajzadegan Z (2018) A comprehensive postpartum follow-up health care program for women with history of preeclampsia: protocol for a mixed methods research. Reprod Health 15(1):81
Paauw ND, Luijken K, Franx A, Verhaar MC, Lely AT (2016) Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin Sci (Lond) 130(4):239–246
Sandvik MK, Leirgul E, Nygård O, Ueland PM, Berg A, Svarstad E, Vikse BE (2013) Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol 209(6):569.e1–569.e10
Vikse BE (2013) Pre-eclampsia and the risk of kidney disease. Lancet 382(9887):104–106
Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, Lu YH (2014) End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol 210(2):147.e1–147.e8
Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, Lin SY, Yen TH, Chuang FR, Chen PC, Huang CC, Wen CP, Sung FC, Morisky DE (2013) Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ 185(3):207–213
Paré E, Parry S, McElrath TF, Pucci D, Newton A, Lim KH (2014) Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol 124(4):763–770
Kattah AG, Scantlebury DC, Agarwal S, Mielke MM, Rocca WA, Weaver AL, Vaughan LE, Miller VM, Weissgerber TL, White W, Garovic VD (2017) Preeclampsia and ESRD: the role of shared risk factors. Am J Kidney Dis 69(4):498–505
Giannakou K, Evangelou E, Papatheodorou SI (2018) Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol 51(6):720–730
Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, Hildebrand AM, Reese PP, Storsley L, Gill JS, Segev DL, Habbous S, Bugeja A, Knoll GA, Dipchand C, Monroy-Cuadros M, Lentine KL (2015) DONOR network. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 372(2):124–133
Tangren JS, Powe CE, Ecker J, Bramham K, Ankers E, Karumanchi SA, Thadhani R (2018) Metabolic and hypertensive complications of pregnancy in women with nephrolithiasis. Clin J Am Soc Nephrol 13(4):612–619
Tangren JS, Wan Md Adnan WAH, Powe CE, Ecker J, Bramham K, Hladunewich MA, Ankers E, Karumanchi SA, Thadhani R (2018) Risk of preeclampsia and pregnancy complications in women with a history of acute kidney Injury. Hypertension 72(2):451–459
Piccoli GB, Fassio F, Attini R, Parisi S, Biolcati M, Ferraresi M, Pagano A, Daidola G, Deagostini MC, Gaglioti P, Todros T (2012) Pregnancy in CKD: Whom should we follow and why? Nephrol Dial Transplant 27(Suppl 3):iii111–iii118
Brouwers L, van der Meiden-van Roest AJ, Savelkoul C, Vogelvang TE, Lely AT, Franx A, van Rijn BB (2018) Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG. 125(13):1642–1654. https://doi.org/10.1111/1471-0528.15394
Boghossian NS, Yeung E, Mendola P, Hinkle SN, Laughon SK, Zhang C, Albert PS (2014) Risk factors differ between recurrent and incident preeclampsia: a hospital-based cohort study. Ann Epidemiol 24(12):871-7e3
van Oostwaard MF, Langenveld J, Schuit E, Papatsonis DN, Brown MA, Byaruhanga RN, Bhattacharya S, Campbell DM, Chappell LC, Chiaffarino F, Crippa I, Facchinetti F, Ferrazzani S, Ferrazzi E, Figueiró-Filho EA, Gaugler-Senden IP, Haavaldsen C, Lykke JA, Mbah AK, Oliveira VM, Poston L, Redman CW, Salim R, Thilaganathan B, Vergani P, Zhang J, Steegers EA, Mol BW, Ganzevoort W (2015) Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am J Obstet Gynecol 212(5):624.e1–624.e17
Williams D, Davison J (2008) Chronic kidney disease in pregnancy. BMJ 336(7637):211–215
Lopes van Balen VA, Spaan JJ, Cornelis T, Spaanderman MEA (2017) Prevalence of chronic kidney disease after preeclampsia. J Nephrol 30(3):403–409
Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A (2018) World Kidney Day Steering Committee. What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Woman’s Day. BMC Nephrol 19(1):66
Madazli R, Yuksel MA, Imamoglu M, Tuten A, Oncul M, Aydin B, Demirayak G (2014) Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia. Arch Gynecol Obstet 290(1):53–57
Lisonkova S, Joseph KS (2013) Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 209(6):544.e1–544.e12
Cross JC (2003) The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet 64(2):96–103
James JL, Whitley GS, Cartwright JE (2010) Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol 221(4):363–378
Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA (2013) Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 32(2):189–201
Piccoli GB, Gaglioti P, Attini R, Parisi S, Bossotti C, Olearo E, Oberto M, Ferraresi M (2013) Pre-eclampsia or chronic kidney disease? The flow hypothesis. Nephrol Dial Transplant 28(5):1199–1206
Rolfo A, Attini R, Nuzzo AM, Piazzese A, Parisi S, Ferraresi M, Todros T, Piccoli GB (2013) Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int 83(1):177–181
Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P, Poston L, Chappell LC (2016) Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89(4):874–885
Attini R, Kooij I, Montersino B, Fassio F, Gerbino M, Biolcati M, Versino E, Todros T, Piccoli GB (2018) Reflux nephropathy and the risk of preeclampsia and of other adverse pregnancy-related outcomes: a systematic review and meta-analysis of case series and reports in the new millennium. J Nephrol. 31(6):833–846. https://doi.org/10.1007/s40620-018-0515-1
Piccoli GB, Kooij IA, Attini R, Montersino B, Fassio F, Gerbino M, Biolcati M, Cabiddu G, Versino E, Todros T (2018) A systematic review on materno-foetal outcomes in pregnant women with IgA nephropathy: a case of “late-maternal” preeclampsia? J Clin Med 7(8):212. https://doi.org/10.3390/jcm7080212
Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N, Tuveri M, Massidda M, Marchi C, Mura S, Coscia A, Biolcati M, Gaglioti P, Nichelatti M, Pibiri L, Chessa G, Pani A, Todros T (2015) Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26(8):2011–2022
Jeyabalan A (2013) Epidemiology of preeclampsia: impact of obesity. Nutr Rev 71(Suppl 1):S18–S25
Patro Golab B, Santos S, Voerman E, Lawlor DA, Jaddoe VWV, Gaillard R, MOCO Study Group Authors (2018) Influence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity: an individual participant data meta-analysis. Lancet Child Adolesc Health 2(11):812–821
Marshall NE, Biel FM, Boone-Heinonen J, Dukhovny D, Caughey AB, Snowden JM (2019) The association between maternal height, body mass index, and perinatal outcomes. Am J Perinatol. 36(6):632–640. https://doi.org/10.1055/s-0038-1673395
Acknowledgements
To Susan Finnel for her careful language correction.
Funding
No funding was obtained for this study. The Centre Hospitalier Le Mans supported language correction and publication fees.
Author information
Authors and Affiliations
Contributions
Study design: GBP, ZFK; RA; extraction of data: ZFK, AF, AC; statistical analysis: MB; patient follow-up: nephrology GBP, AF, ZFK; obstetrics: DL, MTC; drafting of paper: GBP, ZFK, MTC; all authors read and approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has any conflict of interest.
Ethical approval
The study protocol was approved by the ethics committee of the Centre Hospitalier Le Mans (session of 14/06/2018).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the topical collection on Obstetric Nephrology.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Filali Khattabi, Z., Biolcati, M., Fois, A. et al. Chronic kidney disease in preeclamptic patients: not found unless searched for—Is a nephrology evaluation useful after an episode of preeclampsia?. J Nephrol 32, 977–987 (2019). https://doi.org/10.1007/s40620-019-00629-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-019-00629-8